Competa, Radzmer .

HRN: 27-70-42  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/05/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/05/2025
09/12/2025
IV
200mg
Q8h
T/c Surgical Site Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: Compliant To Guidelines